2023_Technolution_Leaderboard

SUSTAINABILITY

RETHINKING PLASTIC: HOW ECO-FRIENDLY DESIGN IS DRIVING SUSTAINABLE CHANGE

Giorgio Sardo discusses sustainable material selection and the results of tests comparing the performance of sustainable bio-based plastic resins with their fossil-based equivalents.

SUSTAINABILITY IN DRUG DELIVERY: HOW DO WE GET THERE?

Tim Wooller discusses the urgent need to transition away from disposable models of drug delivery device design and move towards reusables, providing insights into the reasons why and the methods by which this can be achieved.

TACKLING DESIGN CHALLENGES IN EMERGENCY-USE AUTOINJECTORS

TACKLING DESIGN CHALLENGES IN EMERGENCY-USE AUTOINJECTORS

John Burke considers the challenges that manufacturers need to overcome when designing emergency-use autoinjectors.

WHY SUSTAINABLE PACKAGING MATTERS IN PHARMA’S CIRCULAR APPROACH – APTAR PHARMA’S FUTURITY PLATFORM LEADS THE WAY

WHY SUSTAINABLE PACKAGING MATTERS IN PHARMA’S CIRCULAR APPROACH – APTAR PHARMA’S FUTURITY PLATFORM LEADS THE WAY

Julien Storz discusses the importance of sustainable packaging in the pharma industry and introduces the company’s Futurity platform and its role in product circularity.

DESIGNING SUSTAINABILITY INTO PHARMACEUTICAL DEVICES

DESIGNING SUSTAINABILITY INTO PHARMACEUTICAL DEVICES

Will Davies discusses in detail how to address the challenges of designing sustainability into pharmaceutical devices.

IMPROVING RECYCLABILITY IN DRUG DELIVERY

Julien Tremblin

IMPROVING RECYCLABILITY IN DRUG DELIVERY

Julien Tremblin looks at the recyclability challenges facing the drug delivery market and considers how companies can enhance the recyclability of their packaging and devices.

COMMITTED TO SUSTAINABILITY!

Sandrine Coutarel

COMMITTED TO SUSTAINABILITY!

Sandrine Coutarel looks at the company’s sustainability road map and the steps being taken to achieve its aims.

NAVIGATING pMDI REFORMULATION 2.0

NAVIGATING pMDI REFORMULATION 2.0

Chris Baron and William Ganley examine possible responses to the environmental impact of pressurised metered dose inhalers use and consider alternative inhaler types, with a focus on the strategies and support that can accelerate the development of the next generation of pMDIs.

CONSIDERATIONS WHEN SWITCHING FROM CURRENT pMDI PROPELLANTS TO NEW LOWER-GWP PROPELLANTS

CONSIDERATIONS WHEN SWITCHING FROM CURRENT pMDI PROPELLANTS TO NEW LOWER-GWP PROPELLANTS

Mark Parry discusses the considerations that need to be made when switching from current pressurised metered dose inhaler propellants to new alternatives with lower global warming potential, including formulation, regulatory and analytical standpoints.

SUSTAINABLE DESIGN & MANUFACTURE IN MEDICAL DEVICES: WHERE TO START

SUSTAINABLE DESIGN & MANUFACTURE IN MEDICAL DEVICES: WHERE TO START

Cormac O’Prey discusses the challenges and advantages of implementing circular economy principles in the medical device sector, with a particular consideration of the difficulty of making remanufacturing work for high-volume, low-value devices.

WHY PARTNERSHIPS ARE KEY TO A MORE SUSTAINABLE PHARMA INDUSTRY

WHY PARTNERSHIPS ARE KEY TO A MORE SUSTAINABLE PHARMA INDUSTRY

Peter Hirst argues that careful selection of partners and better collaboration throughout the supply chain are key to optimising the sustainability of the pharmaceutical industry.

MAKING SUSTAINABILITY BY DESIGN THE LINTEL OF SUSTAINABLE INHALER DEVELOPMENT

MAKING SUSTAINABILITY BY DESIGN THE LINTEL OF SUSTAINABLE INHALER DEVELOPMENT

Phil Seeney, Philip Winkworth and Craig Nelson provide an insight into sustainability developments in the pharmaceutical industry, with a focus on inhalables.

CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA

Dr Iain Simpson

Phillips-Medisize

CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA

Iain Simpson and Vinith Bhandari consider the sustainability impact of device connectivity specific to asthma inhalers through the reduction of greenhouse gas emissions.

SUSTAINABILITY MEASURES ARE THE KEY TO MEETING ESG COMMITMENTS

Matthias Birkhoff

SUSTAINABILITY MEASURES ARE THE KEY TO MEETING ESG COMMITMENTS

Matthias Birkhoff and Christophe Marie discuss the advances Aptar Pharma has made in delivering on its sustainability objectives.

YPSOMED’S TWO-STEP APPROACH TO ACHIEVING NET ZERO

Sebastian Gerner

YPSOMED’S TWO-STEP APPROACH TO ACHIEVING NET ZERO

Sebastien Gerner discusses Ypsomed’s approach to achieving its net zero objectives, both looking back at Step One of the company’s approach and outlining the upcoming Step Two.

THE ENVIRONMENTAL IMPACT OF GLOBAL SUPPLY CHAIN LOGISTICS & SUPPLIER SELECTION

Alastair Willoughby

THE ENVIRONMENTAL IMPACT OF GLOBAL SUPPLY CHAIN LOGISTICS & SUPPLIER SELECTION

Alastair Willoughby looks at the factors affecting sustainability when considering global supply chain logistics and supplier selection.

CLIMATE CHANGE AND THE PHARMACEUTICAL INDUSTRY: TOO LITTLE, TOO LATE?

Catriona Eldridge

CLIMATE CHANGE AND THE PHARMACEUTICAL INDUSTRY: TOO LITTLE, TOO LATE?

Catriona Eldridge and Omar Shah discuss the findings of a recent investigative assessment into the environmental impact of healthcare products, and consider whether or not the pharmaceutical industry is doing enough to combat climate change.

SUSTAINABLE DESIGN FOR MEDICAL DEVICES

Stefano Vicenzetto

SUSTAINABLE DESIGN FOR MEDICAL DEVICES

How do you meet environmental and sustainability objectives when designing medical devices? And what design considerations enable the technical cycles, known as the 4R loops of circular economy: reuse, repair, remanufacture and recycle? Stefano Vicenzetto explores the Flex approach to design for environment for medical devices.

ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS

ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS

Tom Mayer discusses how Sonceboz’s vial-based on-body injector – the LVI-V – can expedite the launch of large-volume SC delivery of biologics by leveraging existing primary container technology, reducing associated risks and total cost of ownership.

EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM

Dr Fred Metzmann

EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM

Fred Metzmann and Chris Muenzer discuss the simplicity of the PiccoJect™ autoinjector platform and the company's commitment to sustainability.

ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?

ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?

Rob Udale, Catriona Eldridge and Omar Shah assess the assertion that pMDIs are the most environmentally damaging of the available pulmonary drug delivery device archetypes, and explore some of the intricacies not accounted for in the public discourse surrounding pMDIs.

SUSTAINABILITY: WHAT CAN THE HEALTHCARE SECTOR LEARN FROM CONSUMER DESIGN?

Cambridge Design Partnership

SUSTAINABILITY: WHAT CAN THE HEALTHCARE SECTOR LEARN FROM CONSUMER DESIGN?

Fran Penrose considers the lessons the healthcare sector can draw from the fast-moving consumer sector when designing for sustainability and asks, “Can we go even further?”

SUSTAINABILITY IN MEDTECH DEVELOPMENT: AN ITERATIVE APPROACH BASED ON ECODESIGN AND LIFE CYCLE SCREENINGS

Christoffer Thomsen

SUSTAINABILITY IN MEDTECH DEVELOPMENT: AN ITERATIVE APPROACH BASED ON ECODESIGN AND LIFE CYCLE SCREENINGS

Life Cycle Assessments are a valuable but time-consuming and, ultimately, retrospective method for assessing MedTech product sustainability. Christoffer Thomsen and Peter Werner Hansen dive into an iterative and data-driven approach to more sustainable MedTech development based on Ecodesign and Life Cycle Screenings.

SMART SOLUTIONS TO REDUCE CARBON FOOTPRINT

SMART SOLUTIONS TO REDUCE CARBON FOOTPRINT

Rob Doorakkers and Geert van Amstel discuss why the company decided to become carbon neutral, how it is working to make injection moulding more sustainable and how the organisation is minimising its impact on the environment.

DESIGNING DRUG DELIVERY DEVICES TO MEET EMERGING NEEDS AND SUSTAINABILITY GOALS

Dr Pierre Moulinie

DESIGNING DRUG DELIVERY DEVICES TO MEET EMERGING NEEDS AND SUSTAINABILITY GOALS

Pierre Moulinié, Isaac Platte and Lauren Zetts discuss how polycarbonate-based materials deliver value to emerging drug delivery devices.

HOW CAN THE PHARMA INDUSTRY PREPARE FOR NEW pMDI PROPELLANTS?

HOW CAN THE PHARMA INDUSTRY PREPARE FOR NEW pMDI PROPELLANTS?

Nick Atkinson looks at the changes that are set to hit pressurised metered dose inhaler manufacturing as new propellants are introduced and how pharma companies can prepare for the switch.

CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY

Dr Jnanadeva Bhat

CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY

Jnanadeva Bhat and Anita Solanki discuss the role that hard capsules are able to play in delivering a more sustainable pharmaceutical industry, both as an oral solid dosage form and in dry powder inhalers.

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: THE ROUTE TO FURTHER IMPROVEMENTS

Phillips-Medisize

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: THE ROUTE TO FURTHER IMPROVEMENTS

Emil Fraenkel and Bjarne Sørensen investigate the route to further sustainability improvements for the Aria autoinjector. This article is a sequel to a benchmark study on the environmental impact of Aria presented by Phillips-Medisize in ONdrugDelivery Issue 126 (Oct/Nov 2021).

SUSTAINABILITY CONSIDERATIONS FOR END-TO-END DRUG DELIVERY DEVICE SOLUTIONS

SUSTAINABILITY CONSIDERATIONS FOR END-TO-END DRUG DELIVERY DEVICE SOLUTIONS

Barbara Lead outlines the sustainability efforts undertaken by SMC Group associated companies, including facilitating the transition from hospital to at-home treatment and investment in greener facilities.

INVESTIGATING THE PROPELLANT PATHWAYS LEADING TO A SUSTAINABLE FUTURE FOR MDIS

INVESTIGATING THE PROPELLANT PATHWAYS LEADING TO A SUSTAINABLE FUTURE FOR MDIS

Chris Baron and Jag Shur discuss the various dynamics involved in realising the full potential of MDIs to deliver both improved environmental performance and even better patient outcomes.

WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022

WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022

Rob Udale and Heather Jameson discuss the exciting developments taking place in the design of inhalation devices and share their predictions for the top five inhalation trends to watch as 2022 unfolds, and beyond.

SO FAR SO GOOD: MAINTAINING THE MOMENTUM OF PROGRESS FOR SUSTAINABLE POLICIES

SO FAR SO GOOD: MAINTAINING THE MOMENTUM OF PROGRESS FOR SUSTAINABLE POLICIES

Michael Earl discusses the highlights of a review undertaken by Owen Mumford into how the pharmaceutical industry is faring on environmental, social and governance standards, noting that while the industry is performing above average overall, there remain some key areas for improvement.

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis looks at the factors that should be considered when designing devices with a view to sustainable connectivity.

TOWARDS A MORE SUSTAINABLE FUTURE WITH pMDI SOLUTIONS

TOWARDS A MORE SUSTAINABLE FUTURE WITH pMDI SOLUTIONS

Howard Burnett, Chris Baron and Jay Bhogaita summarise the findings of a recent forum that looked at the development of more sustainable pressurised metered dose inhalers.

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner

Alliance to Zero

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner, Robert O’Beirn and Sabrina Gérard talk with ONdrugDelivery about the Alliance to Zero, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.

SUCCESSFULLY BALANCING THE NEEDS OF THE PLANET WITH THE NEEDS OF THE PATIENT

SUCCESSFULLY BALANCING THE NEEDS OF THE PLANET WITH THE NEEDS OF THE PATIENT

Christophe Marie, Taylor Price and Julien Storz chart the commitments and progress made to date by Aptar in achieving its sustainability targets. The authors also provide examples of integrated, circular economy initiatives undertaken by Aptar Pharma at a product solution level and comment on concrete commitments that can be made to further progress towards sustainability.

SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED

Kindeva Drug Delivery

SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED

Louise Righton busts six sustainability myths about inhalers.

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

Peter Soelkner and Thomas Otto discuss how the pharmaceutical service provider focuses on sustainability.

1
2
Next

Top